Melasma Pharmaceuticals is spin off company of Micar Innovation, registered in Sofia, Bulgaria. Under terms of the agreement, Micar Innovation grants Melasma Pharmaceuticals (Sofia - Bulgaria) an exclusive option to license and develop MIC8411 drugs targeting Melasma disease. Melasma Pharmaceuticals capital is in the hands of Micar Innovation driven by impact and provide value to our future investors.
Company Details
- Founded
- -
- Address
- 38a, Karamfil Street, Sofia,bg 1616,bulgaria
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://Melasma.Life
- Keywords
- weston.
- HQ
- Sofia, BG
Melasma Pharmaceuticals Questions
Melasma Pharmaceuticals's website is http://Melasma.Life
Melasma Pharmaceuticals's LinkedIn profile is https://bg.linkedin.com/company/melasma-pharmaceuticals
Melasma Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Melasma Pharmaceuticals's top competitors are
Primus Pharmaceuticals,
Sanuscure Pharmaceuticals,
Vital Pharmaceuticals, Inc Vpx,
Cnbx Pharmaceuticals,
Jato De Plasma,
Bih Pharmaceuticals Ltd.,
Pancreatic Pharmaceuticals,
Ge Pharmaceuticals Ltd.,
Micar Innovation (Micar21.com),
Food As Medicine Summit.
Melasma Pharmaceuticals's categories are Pharmaceutical Manufacturing
Melasma Pharmaceuticals's founding year is 2018
